Triple

T21228251
Position Surface form Disambiguated ID Type / Status
Subject Conditional Marketing Authorization by European Medicines Agency E523137 entity
Predicate regulatedBy P86 FINISHED
Object Commission Regulation (EC) No 507/2006 NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Commission Regulation (EC) No 507/2006 | Statement: [Conditional Marketing Authorization by European Medicines Agency, regulatedBy, Commission Regulation (EC) No 507/2006]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Commission Regulation (EC) No 507/2006
Context triple: [Conditional Marketing Authorization by European Medicines Agency, regulatedBy, Commission Regulation (EC) No 507/2006]
  • A. Council Regulation (EC) No 510/2006
    Council Regulation (EC) No 510/2006 was an EU law establishing the system for protecting geographical indications and designations of origin for agricultural products and foodstuffs before being replaced by Regulation (EU) No 1151/2012.
  • B. Council Regulation (EC) No 768/2005
    Council Regulation (EC) No 768/2005 is a European Union legal act that established the framework for creating the European Fisheries Control Agency and harmonizing fisheries control and inspection across member states.
  • C. Regulation (EC) No 1901/2006
    Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
  • D. Council Regulation (EC) No 6/2002
    Council Regulation (EC) No 6/2002 is a key European Union legislative act that establishes the legal framework for Community designs, including their registration, protection, and enforcement across the EU.
  • E. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Commission Regulation (EC) No 507/2006
Target entity description: Commission Regulation (EC) No 507/2006 is an EU legal act that sets the rules and procedures for granting conditional marketing authorizations for medicinal products for human use.
  • A. Council Regulation (EC) No 510/2006
    Council Regulation (EC) No 510/2006 was an EU law establishing the system for protecting geographical indications and designations of origin for agricultural products and foodstuffs before being replaced by Regulation (EU) No 1151/2012.
  • B. Council Regulation (EC) No 768/2005
    Council Regulation (EC) No 768/2005 is a European Union legal act that established the framework for creating the European Fisheries Control Agency and harmonizing fisheries control and inspection across member states.
  • C. Regulation (EC) No 1901/2006
    Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
  • D. Council Regulation (EC) No 6/2002
    Council Regulation (EC) No 6/2002 is a key European Union legislative act that establishes the legal framework for Community designs, including their registration, protection, and enforcement across the EU.
  • E. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b512ad94819087942b2ed925185f completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e734ad5068819088b203eeba4e6380 completed April 21, 2026, 8:26 a.m.
Created at: April 16, 2026, 3:44 p.m.